Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,272,955
  • Shares Outstanding, K 64,582
  • Annual Sales, $ 508,820 K
  • Annual Income, $ -67,090 K
  • EBIT $ -174 M
  • EBITDA $ -180 M
  • 60-Month Beta 0.84
  • Price/Sales 16.20
  • Price/Cash Flow N/A
  • Price/Book 24.09

Options Overview Details

View History
  • Implied Volatility 6.19% ( -4.10%)
  • Historical Volatility 79.97%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 71.56% on 02/11/25
  • IV Low 6.19% on 06/05/25
  • Put/Call Vol Ratio 1.55
  • Today's Volume 863
  • Volume Avg (30-Day) 979
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 39,153
  • Open Int (30-Day) 32,510

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.54
  • Number of Estimates 10
  • High Estimate -0.15
  • Low Estimate -0.78
  • Prior Year -0.80
  • Growth Rate Est. (year over year) +32.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
94.38 +35.52%
on 05/29/25
128.24 -0.26%
on 06/05/25
+26.07 (+25.60%)
since 05/05/25
3-Month
73.04 +75.11%
on 04/09/25
128.24 -0.26%
on 06/05/25
+37.98 (+42.24%)
since 03/05/25
52-Week
73.04 +75.11%
on 04/09/25
128.24 -0.26%
on 06/05/25
+22.08 (+20.87%)
since 06/05/24

Most Recent Stories

More News
Stocks Set to Open Lower as Trade Tensions Flare, U.S. Jobs Data and Powell Speech Awaited

June S&P 500 E-Mini futures (ESM25) are down -0.57%, and June Nasdaq 100 E-Mini futures (NQM25) are down -0.69% this morning, starting the new month on a downbeat note as escalating global trade tensions...

SAN.FP : 87.800 (+0.35%)
ULTA : 467.04 (+0.30%)
AVGO : 259.93 (-0.44%)
CRWD : 462.94 (+0.52%)
DLTR : 96.67 (+9.08%)
ESM25 : 5,970.75 (+0.42%)
LULU : 330.78 (-1.32%)
TSLA : 284.70 (-14.26%)
ZS : 300.88 (+1.36%)
BPMC : 127.90 (-0.16%)
NQM25 : 21,665.50 (+0.39%)
REGN : 483.07 (-0.38%)
Blueprint Medicines: Q1 Earnings Snapshot

Blueprint Medicines: Q1 Earnings Snapshot

BPMC : 127.90 (-0.16%)
Blueprint Medicines: Q4 Earnings Snapshot

Blueprint Medicines: Q4 Earnings Snapshot

BPMC : 127.90 (-0.16%)
Blueprint Stock Soars 18% on Encouraging 2025 Growth Strategy

Shares of Blueprint Medicines BPMC rallied 18.2% on Monday driven by investor enthusiasm following the company’s announcement of its 2025 corporate outlook and growth strategy, highlighting plans to...

CTMX : 2.40 (-4.38%)
CSTL : 17.02 (unch)
BPMC : 127.90 (-0.16%)
HALO : 53.55 (-0.56%)
Insider Sale: PRINCIPAL ACCOUNTING OFFICER of $BPMC (BPMC) Sells 1,200 Shares

Ariel Hurley, the PRINCIPAL ACCOUNTING OFFICER of $BPMC ($BPMC), sold 1,200 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

BPMC : 127.90 (-0.16%)
Insider Sale: CHIEF OPERATING OFFICER of $BPMC (BPMC) Sells 2,274 Shares

Christina Rossi, the CHIEF OPERATING OFFICER of $BPMC ($BPMC), sold 2,274 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1%...

BPMC : 127.90 (-0.16%)
Blueprint Medicines: Q3 Earnings Snapshot

Blueprint Medicines: Q3 Earnings Snapshot

BPMC : 127.90 (-0.16%)
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

For Immediate ReleaseChicago, IL – October 25, 2024 – Today, Zacks Equity Research discusses Exelixis, Inc, EXEL, Blueprint Medicines BPMC, CRISPR Therapeutics CRSP, Amicus Therapeutics FOLD and Verona...

FOLD : 5.96 (-2.30%)
CRSP : 38.57 (+1.37%)
VRNA : 85.54 (+1.86%)
EXEL : 42.37 (+0.36%)
BPMC : 127.90 (-0.16%)
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major...

FOLD : 5.96 (-2.30%)
CRSP : 38.57 (+1.37%)
VRNA : 85.54 (+1.86%)
EXEL : 42.37 (+0.36%)
BPMC : 127.90 (-0.16%)
Blueprint Medicines: Q2 Earnings Snapshot

Blueprint Medicines: Q2 Earnings Snapshot

BPMC : 127.90 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Blueprint Medicines Corporation is a biopharmaceutical company focused on developing the potentially transformational precision medicines to address patients with genomically defined cancers and rare diseases.

See More

Key Turning Points

3rd Resistance Point 128.56
2nd Resistance Point 128.40
1st Resistance Point 128.15
Last Price 127.90
1st Support Level 127.74
2nd Support Level 127.58
3rd Support Level 127.33

See More

52-Week High 128.24
Last Price 127.90
Fibonacci 61.8% 107.15
Fibonacci 50% 100.64
Fibonacci 38.2% 94.12
52-Week Low 73.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »